Healthcare
NeuroOne to Present at Planet MicroCap Las Vegas 2026 Conference, Highlighting OneRF Platform Progress
NeuroOne Medical Technologies will present at the Planet MicroCap Las Vegas 2026 Conference, providing updates on its OneRF platform for brain treatment, pain, and drug delivery, signaling continued momentum in neurological device commercialization.
Lifordi Immunotherapeutics Reports Positive Phase 1 Data for LFD-200 in Autoimmune Disease
Phase 1 data for LFD-200, a subcutaneous glucocorticoid antibody-drug conjugate, shows anti-inflammatory activity without systemic steroid toxicity, with patient dosing ongoing in rheumatoid arthritis.
Nefense Launches Hypochlorous Acid Nasal Spray Line for All Ages
Nefense introduces Hyponasal, Hyponasal Junior, and Hypobaby, a drug-free HOCl nasal spray family targeting airway hygiene for adults, children, and infants, responding to growing consumer interest in respiratory wellness.
Nefense Launches Hypochlorous Acid Nasal Spray Line for Age-Specific Airway Hygiene
Nefense introduces a new hypochlorous acid nasal spray line for adults, children, and infants, offering a safe, antimicrobial solution for respiratory hygiene and seasonal allergy relief.
Voyageur Pharmaceuticals Closes $5 Million Private Placement to Advance Barium and Iodine Contrast Products
Voyageur Pharmaceuticals has closed a $5 million private placement, raising funds for FDA licensing of its barium contrast suite and development of its Frances Creek barite project and U.S. iodine project.
Los Angeles County Health Officials Issue Infectious Disease Alert Ahead of World Cup Matches
With World Cup matches set to draw massive crowds to SoFi Stadium, LA's health department urges providers to watch for infectious diseases, highlighting the need for rapid testing capabilities.
Oncotelic Therapeutics Integrates AI, Nanomedicine, and Robotics to Boost Precision Oncology and Rare Disease Treatments
Oncotelic Therapeutics is leveraging its PDAOAI ecosystem, Deciparticle nanomedicine platform, and robotics to accelerate therapies for cancer and rare diseases, positioning itself at the forefront of precision oncology and automation.
MindBio Therapeutics Targets Growing Demand for Non-Invasive Impairment Detection with AI Voice Analysis
MindBio Therapeutics is developing AI-powered voice analysis to detect drug and alcohol impairment, addressing the need for faster, less invasive workplace testing in mining and other industries as the global market grows.
Norris Self-Ligating Braces Now Exclusive to One Seacoast Orthodontic Practice
Seacoast Braces / Miller Orthodontics becomes the only provider of the Dynaflex Norris Passive Self-Ligating Bracket System in Dover and Exeter, New Hampshire, offering patients a friction-reducing alternative to traditional braces.
Sydney Clinic Expands Services to Accelerate WorkCover and CTP Claims with Same-Day Certificates
Sydney Injury Doctors now offers same-day Certificates of Capacity for injured workers and motor accident patients, streamlining the claims process and emphasizing patient choice in selecting their treating doctor.
HighTide Therapeutics Unveils New Data Supporting HTD1801's Renoprotective Effects at ERA 2026
New findings from HighTide Therapeutics show that its lead candidate HTD1801 protects kidney function by targeting podocyte inflammation and apoptosis, offering potential as a disease-modifying therapy for chronic kidney disease.
Colombia Nonprofit Integrates Mental Health Into Community Empowerment Model
Centro de Transformacion Integral launches a structured initiative combining mental health support, education, and social programs to address interconnected community challenges across Colombia.
New Allied Health Coworking Space Opens in Revesby to Address Clinical Workspace Shortage
My Health Network has launched a purpose-built medical coworking space in Revesby, NSW, filling a gap in suitable clinical workspace for allied health practitioners in the region.
Oncotelic Therapeutics Advances Nanoparticle Drug Delivery Platform to Improve Cancer Treatment Outcomes
Oncotelic Therapeutics is leveraging its Deciparticle platform and Sapu003 program to enhance drug delivery for existing cancer therapies, addressing key challenges in oncology treatment.
American Heart Association Launches Stroke Coordinator Certification to Elevate Stroke Care Quality
The American Heart Association's new Stroke Coordinator Certification aims to validate expertise in managing stroke programs, improving patient outcomes, and supporting career advancement for healthcare professionals.
LataMed AI Collaborates with Universidad Central de Venezuela Faculty of Medicine to Advance HealthTech Education
LataMed AI Corp. partners with Universidad Central de Venezuela's Faculty of Medicine for educational sessions on digital health and AI, aiming to foster innovation among future healthcare professionals in Latin America.
Fenway Park Hosts CPR Training for 400 During National CPR Week, Highlighting Bystander Intervention
The Red Sox Foundation and American Heart Association trained 400 people in Hands-Only CPR at Fenway Park, emphasizing the critical role of bystanders in improving survival from sudden cardiac arrest.
‘Invisible Wellness’ Concept Gains Traction as Florida Builder Integrates Health into Home Design
Ryan Hinricher’s Sunworth homes embed health features like natural light and tree views into structural design, challenging the industry’s focus on add-on amenities.
Qiari.ai Launches AI-Powered Frequency Wellness Platform for Personalized Remote Sessions
Qiari.ai introduces an AI-driven frequency wellness platform that delivers personalized remote sessions, marking a shift from static protocols to intelligent, adaptive digital health experiences.
Microglia Protein Production Linked to Pediatric Brain Tumor Spread, Study Finds
Scientists discovered that microglia in the brain produce fibronectin proteins, enabling diffuse midline gliomas to spread, highlighting a potential therapeutic target for companies like CNS Pharmaceuticals.
Stonegate Capital Partners Updates Coverage on Cingulate Inc. Following FDA Complete Response Letter
Cingulate Inc. faces a CMC-driven resubmission process for CTx-1301 after FDA issues Complete Response Letter, but strong cash position and intact product thesis suggest timeline rather than viability is the key concern.
NWSL and American Heart Association Launch CPR Ambassador Program Ahead of Awareness Week
The National Women's Soccer League and American Heart Association announced a 2026 ambassador class of players, led by cardiac arrest survivor Savy King, to promote Hands-Only CPR education across all 16 clubs.
Quantum BioPharma Diversifies Pipeline to Address Neurological and Wellness Markets
Quantum BioPharma is advancing a novel MS therapy and expanding into alcohol health with unbuzzd, targeting unmet needs in neurological care and consumer wellness.
Regentis Biomaterials' GelrinC Targets Large Untapped Market for Off-the-Shelf Cartilage Repair
Regentis Biomaterials is advancing its GelrinC platform toward commercialization, aiming to fill the gap in FDA-approved off-the-shelf regenerative cartilage repair for the 470,000 annual U.S. knee cartilage damage cases.
San Diego Practice Merges Pediatric Dentistry and Orthodontics Under One Roof
4S Pediatric Dentistry & Orthodontics launches integrated care model for children's dental and orthodontic needs, easing logistical burdens for families.
Oncotelic Therapeutics Highlighted in BioMedWire Editorial as Drug-Delivery Market Nears $410 Billion Opportunity
Oncotelic Therapeutics (OTCQB: OTLC) was featured in a BioMedWire editorial examining the growing drug-delivery market, highlighting its Sapu003 and Deciparticle platform as nanotechnology-driven approaches to improve existing therapies.
Kairos Pharma Expands Oncology Pipeline with Proposed Acquisition of Phase 1-Ready c-MET Inhibitor
Kairos Pharma's mid-year update reveals plans to acquire CL-741, a Phase 1-ready oral c-MET inhibitor, expand clinical trials for ENV-105, and secure over $8 million in non-dilutive funding, signaling significant pipeline growth and potential advancements in cancer treatment.
American Heart Association Selects Eight Startups for Heart and Brain Health Accelerator
Eight innovative health tech companies have been chosen to participate in the 2026 Heart and Brain Health Accelerator, a collaboration between the American Heart Association and MedTech Innovator, aiming to advance cardiovascular and neurological care through novel technologies.
NeuroThera Labs Acquires Majority Stake in CliniQuantum, Merging Quantum Computing with Clinical Trials
NeuroThera Labs Inc. has closed its acquisition of a 54.01% stake in CliniQuantum Ltd., aiming to enhance clinical trial precision through quantum simulation and Monte Carlo methods.
Helix BioPharma Raises C$3.67M in Convertible Debenture Offering to Fund Drug Development
Helix BioPharma Corp. closed a private placement of convertible debentures raising C$3.67 million, with proceeds earmarked for working capital and advancement of its oncology drug pipeline.